Share chart Enveric Biosciences, Inc.
Extended chart
Simple chart
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc., биотехнологическая компания, занимается разработкой низкомолекулярных терапевтических средств для лечения тревоги, депрессии и зависимостей. Его ведущей программой является EB-373, активный метаболит псилоцибина, который проходит первую фазу клинических испытаний для лечения тревожных расстройств; ЭВМ-301 для лечения психического здоровья; и конъюгат EV104 CBD + целекоксиб для лечения остеоартрита. more details| IPO date | 2015-06-24 |
|---|---|
| ISIN | US29405E2081 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 100000 |
| Сайт | https://www.enveric.com |
| Цена ао | 1.64 |
| Change price per day: | +5.49% (1.64) |
|---|---|
| Change price per week: | -4.95% (1.82) |
| Change price per month: | +9.49% (1.58) |
| Change price per 3 month: | -68.27% (5.4525) |
| Change price per half year: | -76.98% (7.515) |
| Change price per year: | +57.27% (1.1) |
| Change price per 3 year: | +522.3% (0.278) |
| Change price per 5 year: | +32.06% (1.31) |
| Change price per 10 year: | 0% (1.73) |
| Change price per year to date: | -62.8% (4.65) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| AdvisorShares Investments, LLC | 100429 | 4.83 |
| Blackrock Inc. | 29578 | 1.42 |
| Tower Research Capital LLC (TRC) | 14129 | 0.68 |
| Susquehanna International Group, LLP | 12481 | 0.6 |
| Vanguard Group Inc | 12125 | 0.58 |
| UBS Group AG | 5318 | 0.26 |
| Acadian Asset Management. LLC | 4559 | 0.22 |
| Group One Trading, L.P. | 273 | 0.01 |
| Royal Bank of Canada | 228 | 0.01 |
| Bank of America Corporation | 100 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Joseph Edward Tucker Ph.D. | CEO & Director | 825.94k | 1969 (56 years) |
| Dr. Peter J. Facchini Ph.D. | Chief Innovation Officer | 332.38k | 1964 (61 year) |
| Mr. Kevin M. Coveney CPA | Chief Financial Officer | 1964 (61 year) |
Address: United States, Naples. FL, 4851 Tamiami Trail N - open in Google maps, open in Yandex maps
Website: https://www.enveric.com
Website: https://www.enveric.com
